$1.47
1.73% yesterday
Nasdaq, Nov 25, 09:04 pm CET
ISIN
US03837C1062
Symbol
APYX

Apyx Medical Corporation Stock price

$1.44
+0.23 19.01% 1M
-0.16 10.00% 6M
-1.18 45.04% YTD
-1.50 51.02% 1Y
-14.39 90.90% 3Y
-6.06 80.80% 5Y
-5.25 78.48% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
-0.01 0.35%
ISIN
US03837C1062
Symbol
APYX
Sector

Key metrics

Market capitalization $54.21m
Enterprise Value $65.21m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.34
P/S ratio (TTM) P/S ratio 1.12
P/B ratio (TTM) P/B ratio 4.52
Revenue growth (TTM) Revenue growth -3.49%
Revenue (TTM) Revenue $48.54m
EBIT (operating result TTM) EBIT $-21.57m
Free Cash Flow (TTM) Free Cash Flow $-16.14m
Cash position $28.01m
EPS (TTM) EPS $-0.82
P/E forward negative
P/S forward 1.16
EV/Sales forward 1.39
Short interest 0.73%
Show more

Is Apyx Medical Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Apyx Medical Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Apyx Medical Corporation forecast:

1x Buy
25%
3x Hold
75%

Analyst Opinions

4 Analysts have issued a Apyx Medical Corporation forecast:

Buy
25%
Hold
75%

Financial data from Apyx Medical Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
49 49
3% 3%
100%
- Direct Costs 37 37
1% 1%
76%
12 12
15% 15%
24%
- Selling and Administrative Expenses 27 27
3% 3%
56%
- Research and Development Expense 5.21 5.21
7% 7%
11%
-21 -21
8% 8%
-43%
- Depreciation and Amortization 0.61 0.61
18% 18%
1%
EBIT (Operating Income) EBIT -22 -22
7% 7%
-44%
Net Profit -28 -28
88% 88%
-59%

In millions USD.

Don't miss a Thing! We will send you all news about Apyx Medical Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Apyx Medical Corporation Stock News

Neutral
GlobeNewsWire
14 days ago
CLEARWATER, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced that Charles Goodwin, President and CEO and Matt Hill, CFO will be attending the following upcoming conference:
Neutral
Seeking Alpha
18 days ago
Apyx Medical Corporation (NASDAQ:APYX ) Q3 2024 Earnings Call Transcript November 8, 2024 8:00 AM ET Company Participants Jeremy Feffer - MD, LifeSci Advisors Stavros Vizirgianakis - Executive Chairman Charlie Goodwin - CEO Matt Hill - CFO Conference Call Participants Matthew O'Brien - Piper Sandler Matt Hewitt - Craig-Hallum Capital Group Sam Eiber - BTIG Ben Haynor - Lake Street Capital Marke...
Neutral
GlobeNewsWire
18 days ago
CLEARWATER, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical” or the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced it has entered into a definitive purchase agreement with Nantahala Capital for the purchase and sale in a registered direct offering of ...
More Apyx Medical Corporation News

Company Profile

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

Head office United States
CEO Charles Goodwin
Employees 252
Founded 1978
Website apyxmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today